
This is the pathological mirror of bonding system physiology and cognitive reserve β the degraded state in which the hippocampal bonding hub collapses under sustained neuroinflammation, hypercortisolemia, and social isolation. The same eight-region brain network that builds cognitive reserve through bonding now manifests as a unified syndrome: depression, chronic pain, and chronic fatigue. These are not three separate diseases but three symptomatic faces of the same underlying pathology β the failure of the hippocampal-centered bonding system to maintain neuroplastic reserve, emotional regulation, and homeostatic control.
Imagine a city's central power station (the hippocampus) that normally receives fuel shipments (BDNF from exercise, oxytocin from bonding, serotonin from the RaphΓ© nuclei) and distributes electricity to eight neighborhoods (brain regions: PFC, amygdala, striatum, etc.). In the healthy state, the power station has a backup generator (cognitive reserve), efficient fuel storage (4 million neurons), and clean fuel lines.
Now picture what happens when the fuel trucks stop arriving (the person becomes a "couch potato," loses social bonds) and toxic waste starts being dumped at the power station (TNF, IFN-Ξ³, chronic cortisol flooding the hippocampus). The backup generator sputters down from four stars to one. The fuel storage tanks shrink. The fuel lines get corroded. Toxic sludge (neuroinflammation) gums up the distribution network.
Each neighborhood responds to the power failure differently: the executive district (PFC) can't keep order β anxiety and suicidal thoughts. The pleasure district (substantia nigra, striatum) goes dark β anhedonia. The threat-detection neighborhood (amygdala) gets hypersensitive alarms with no central override β fear and anger. The body-monitoring district (insula) sends confused signals β loss of interoceptive control. The alertness neighborhood (locus coeruleus) runs on emergency mode β nervous exhaustion masked by sugar cravings. The pain-regulation neighborhood (periaqueductal gray, RaphΓ© nuclei) loses its calming neurotransmitters β chronic pain.
The entire city suffers the same power crisis, but each neighborhood's breakdown looks different. That's why the same person can have depression (dark pleasure district), chronic pain (broken pain regulation), and chronic fatigue (energy crisis) simultaneously β it's one infrastructure collapse manifesting across multiple systems.
The healthy hippocampal bonding system (see bonding system physiology and cognitive reserve) operates with:
- 4,000,000 neurons (hippocampal neuronal mass)
- High BDNF from exercise, bonding touch, sensory enrichment β TrkB receptor β CREB β neurogenesis, synaptic plasticity
- Balanced cortisol (morning peak 15-25 ΞΌg/dL, evening trough <5 ΞΌg/dL) β glucocorticoid receptors (GR) β negative feedback on HPA axis
- Serotonin from Nuclei Raphei β 5-HT receptors β mood regulation, pain modulation
- Oxytocin from bonding β OXTR β GR upregulation via NGFBP-1 cascade
- Functional mitochondria β ATP production β synaptic transmission, neuronal survival
The pathological transformation occurs through:
Social isolation, loss of physical touch, sedentary behavior (couch potato) β
- β Oxytocin signaling β β NGFBP-1 β β GR upregulation β impaired cortisol negative feedback
- β Exercise β β BDNF production β β hippocampal neurogenesis
- β Piezoelectric channel activation (TRP3/4) β β mechanosensory-driven neurotrophin release
ΒΆ Step 2: Chronic Stress and HPA Axis Dysregulation
Sustained psychological/physical stressors β
- Chronic cortisol elevation (hypercortisolemia) β loss of circadian rhythm (flat cortisol curve, no morning peak, no evening trough)
- Cortisol >20 ΞΌg/dL sustained β direct neurotoxicity to hippocampal CA3 and dentate gyrus neurons
- GR downregulation (receptor desensitization) β cortisol resistance β loss of negative feedback β more cortisol release β vicious cycle
- Cortisol β β glutamate release β excitotoxicity β neuronal death
- 10-20% hippocampal volume reduction measurable on MRI after 6-12 months of chronic stress
Peripheral inflammation (from gut dysbiosis, metabolic dysfunction, chronic infection) crosses blood-brain barrier β
-
TNF-Ξ± elevation (from 2-5 pg/mL to 15-30 pg/mL in CSF):
- TNF-Ξ± β microglial activation β M1 polarization β further cytokine amplification
- TNF-Ξ± β β hippocampal neurogenesis (suppresses neural stem cell proliferation in dentate gyrus)
- TNF-Ξ± β synaptic stripping (microglia physically remove synapses via complement-mediated phagocytosis)
- TNF-Ξ± β mitochondrial dysfunction (disrupts electron transport chain, β ROS)
- TNF-Ξ± β β BDNF signaling (interferes with TrkB receptor activation)
-
IFN-Ξ³ elevation (Th1 cytokine, normally <2 pg/mL in CSF, rises to 10-25 pg/mL):
- IFN-Ξ³ β activates IDO (indoleamine 2,3-dioxygenase) in astrocytes and microglia
- IDO β shunts tryptophan away from serotonin synthesis toward kynurenine pathway
- Kynurenine β 3-hydroxykynurenine β quinolinic acid (NMDA receptor agonist β excitotoxicity)
- Tryptophan depletion β β serotonin synthesis at Nuclei Raphei β mood dysregulation, β pain inhibition
- This is the molecular mechanism of inflammation-induced depression
-
IL-4 appearance (Th2 cytokine, suggests dysregulated neuroimmune response):
- IL-4 drives alternative microglial activation (M2a phenotype)
- In context of sustained TNF/IFN-Ξ³, IL-4 reflects failed counter-regulation rather than successful resolution
- May contribute to fibrotic processes and failed tissue repair
graph TD
A["Bonding Failure:<br/>β Exercise, β Touch, β Social Support"] --> B["β BDNF, β Oxytocin"]
A --> C[Chronic Stress Exposure]
B --> D["Hippocampal Vulnerability:<br/>β Neurogenesis, β GR"]
C --> E["Chronic Cortisol Elevation<br/>Hypercortisolemia"]
E --> F["GR Downregulation<br/>Cortisol Resistance"]
F --> E
E --> G["Direct Neurotoxicity:<br/>CA3/DG neuronal death"]
C --> H["Peripheral Inflammation:<br/>Gut barrier, metabolic stress"]
H --> I[BBB Breakdown]
I --> J["Neuroinflammation:<br/>TNF-Ξ±, IFN-Ξ³, IL-4"]
J --> K[Microglial M1 Activation]
K --> L[Synaptic Stripping]
K --> M["Tryptophan Steal:<br/>IFN-Ξ³ β IDO β Kynurenine"]
M --> N["β Serotonin Synthesis<br/>Quinolinic Acid β"]
J --> O[Mitochondrial Dysfunction]
O --> P[Energy Crisis]
G --> Q["Hippocampal Atrophy:<br/>4M β 3M neurons<br/>Reserve: 4β
β 1β
"]
L --> Q
P --> Q
Q --> R[8-Region Network Failure]
R --> S["PFC: Anxiety, Suicide"]
R --> T["SN/Striatum: Anhedonia"]
R --> U["Amygdala: Fear, Anger"]
R --> V["Insula: Loss of Control"]
R --> W["LC: Nervosity, Sugar Craving"]
R --> X["NR: Pain Dysregulation"]
R --> Y["VT: Addiction Seeking"]
S --> Z[Clinical Triad]
T --> Z
U --> Z
V --> Z
W --> Z
X --> Z
Y --> Z
Z --> AA[Depression]
Z --> AB[Chronic Pain]
Z --> AC[Chronic Fatigue]
Each brain region responds to the hippocampal failure:
| Region |
Healthy Function |
Pathological Cascade |
Clinical Manifestation |
| Prefrontal cortex (PFC) |
Executive control, emotional regulation via hippocampal input |
Hippocampal atrophy β β PFC-hippocampal connectivity β loss of top-down control β rumination loops |
Anxiety, suicidality β inability to regulate catastrophic thoughts, impaired decision-making |
| Substantia nigra (SN) |
Dopamine synthesis for reward/motivation |
TNF-Ξ± β β tyrosine hydroxylase activity β β dopamine production |
Loss of hedonism β anhedonia, flat affect |
| Hypothalamus |
HPA axis control, appetite, libido |
Chronic cortisol β hypothalamic inflammation β leptin resistance, β GnRH pulsatility |
Libido disorders, appetite dysregulation (anorexia or hyperphagia) |
| Striatum |
Reward processing, goal-directed behavior |
β Dopamine input from SN/VTA β β D2 receptor signaling |
Loss of interest β inability to initiate pleasurable activities |
| Insular cortex |
Interoception, body awareness, emotional processing |
Hippocampal-insular disconnection β disturbed body schema |
Loss of control β alexithymia, disturbed pain perception |
| Amygdala |
Threat detection, emotional memory |
Loss of hippocampal inhibition (normally GR-mediated) β amygdala hyperactivation |
Fear, anger β emotional volatility, threat hypersensitivity |
| Locus coeruleus (LC) |
Norepinephrine release, arousal |
Chronic stress β β CRH drive to LC β norepinephrine depletion with compensatory hyperactivity |
Nervosity, sugar craving β anxious arousal, glucose-seeking behavior (brain's emergency fuel demand) |
| Ventral tegmental area (VT) |
Dopamine for bonding pleasure, reward learning |
Loss of natural reward (bonding) β compensatory dopamine-seeking |
Search behavior, addiction β compulsive seeking (food, screens, substances) |
Nuclei Raphei compromise:
- TNF-Ξ± present at brainstem level β direct inhibition of tryptophan hydroxylase
- IFN-Ξ³ β IDO activation β tryptophan steal β β 5-HTP synthesis
- Result: β Serotonin release β loss of descending pain inhibition, mood destabilization
- Neurosteroid depletion (β allopregnanolone from progesterone metabolism) β β GABA-A receptor potentiation β anxiety, insomnia
Sensory input failure:
- "Couch potato" lifestyle β no exercise-induced BDNF (normally exercise β myokines β brain BDNF β 200-300%)
- Social isolation β β skin-to-skin contact β β piezoelectric channel activation β β oxytocin
- β Sensory enrichment (smell, taste, vision, hearing) β reduced neuroplastic stimulation
- This creates a vicious cycle: symptoms β β activity β β BDNF β worse symptoms
- TNF-Ξ± β mitochondrial membrane permeabilization β β ATP production
- Chronic cortisol β β oxidative stress β mitochondrial DNA damage
- β PGC-1Ξ± expression β β mitochondrial biogenesis
- Result: cellular energy failure β fatigue, cognitive dysfunction, impaired neurotransmitter synthesis
The visual reduction from four stars (healthy bonding triad) to one star represents:
- Loss of the bonding triad (attachment figures, social support network)
- Depletion of cognitive reserve to minimum survival level
- The individual operating in isolated survival mode
- Final buffer before complete hippocampal system collapse
- Hippocampal volume: 10-20% reduction on MRI (particularly CA3 and dentate gyrus)
- Cortisol: Morning >25 ΞΌg/dL or evening >10 ΞΌg/dL (loss of circadian rhythm)
- CSF cytokines: TNF-Ξ± >15 pg/mL, IL-6 >10 pg/mL, IFN-Ξ³ >10 pg/mL
- Kynurenine/Tryptophan ratio: >0.05 (indicates IDO activation, tryptophan steal)
- BDNF: Serum levels <20 ng/mL (normal 25-35 ng/mL)
- Depression scores: PHQ-9 >10, with overlapping chronic pain (β₯3 months) and fatigue (β₯6 months)
This map explains the 67% failure rate of SSRIs in the STAR*D trial. Treating serotonin depletion with SSRIs addresses one downstream consequence while ignoring:
- The inflammatory drivers (TNF-Ξ±, IFN-Ξ³) that continue depleting tryptophan via IDO
- Mitochondrial dysfunction preventing ATP-dependent neurotransmitter synthesis
- GR downregulation perpetuating hypercortisolemia
- BDNF depletion preventing hippocampal repair
- Loss of sensory and bonding inputs that normally drive neuroplasticity
Similarly:
- Analgesics for chronic pain mask symptoms but don't resolve amygdala hyperactivation, neuroinflammation, or failed descending inhibition
- Stimulants for fatigue further deplete catecholamines without addressing mitochondrial energy crisis
- CBT alone attempts cognitive reframing with a damaged PFC and shrunken hippocampus β necessary but insufficient without biological restoration
Based on this pathological map, treatment must simultaneously address:
1. Reduce Neuroinflammation:
- Omega-3 (DHA/EPA): 2-4g daily β competitive inhibition of AA β β inflammatory prostaglandins, β resolvins
- Specialized pro-resolving mediators (SPMs): RvD1, RvD2, MaR1 supplementation
- Gut barrier repair: Remove inflammatory triggers (gluten, dairy if sensitive), zinc carnosine 150mg 2x/day, glutamine 5g/day
- Anti-inflammatory diet: Polyphenols (curcumin 500mg, EGCG, quercetin) β NF-ΞΊB inhibition
2. Restore BDNF:
- Exercise β even 10 minutes walking β myokine release (irisin) β brain BDNF β
- Intermittent Living protocols (cold exposure, fasting windows) β hormetic stress β BDNF β
- Nutritional support: Zinc 30mg, magnesium 400mg, vitamin D3 (target 50-70 ng/mL)
3. Repair Cortisol Rhythm:
- Morning light exposure: 10,000 lux within 30 min of waking β cortisol peak restoration, melatonin suppression
- Evening cortisol reduction: Blue light blocking 2h before bed, magnesium glycinate 400mg, ashwagandha 600mg
- HPA axis support: Rhodiola 300mg, phosphatidylserine 300mg (reduces evening cortisol)
- Address chronic stressors: Five metamodels assessment, trauma-informed therapy
4. Rebuild Sensory-Bonding Input:
- Restore touch: Massage therapy 1-2x/week, partner physical contact, pets
- Social reconnection: Group therapy, support groups, social prescribing
- Sensory enrichment: Nature exposure (multi-sensory: visual, auditory, olfactory), music, aromatherapy
- Break couch potato cycle: Start with 5-10 min movement daily, gradually increase
5. Support Mitochondrial Function:
- Substrates: CoQ10 200mg, alpha-lipoic acid 600mg, B-complex (B1, B2, B3, B12)
- Minerals: Iron (if deficient), copper, selenium
- Exercise: Single most potent mitochondrial biogenesis stimulus
- Cold exposure: Mitochondrial hormesis, β UCP1, β thermogenesis
6. Region-Specific Support:
- PFC: Structured routine, reduce decision fatigue, cognitive scaffolding, omega-3
- Amygdala: Body-based therapies (somatic experiencing, EMDR), vagus nerve stimulation, breathing exercises (4-7-8 breathing)
- LC: Stabilize blood glucose (protein breakfast, avoid sugar spikes), reduce caffeine
- VT/Striatum: Healthy reward sources (nature, music, social connection), meaning-based activities
- Insula: Mindfulness, body scan meditation, interoceptive training
- SN/Hypothalamus: Circadian restoration, appetite normalization, address libido through hormonal balance
7. Serotonin Pathway Support:
- Address IDO activation: Anti-inflammatory interventions (above)
- Support tryptophan conversion: B6 100mg, B3 500mg, vitamin C 1000mg
- 5-HTP supplementation (50-100mg) bypasses tryptophan hydroxylase limitation
- Note: Only after inflammation controlled; otherwise tryptophan still shunted to kynurenine
This pathology intersects all five metamodels:
Metamodel 1 (Genetics/Evolution):
- Evolutionary mismatch β modern social isolation, sedentary behavior, chronic stress incompatible with evolved bonding-movement-community needs
- Some individuals have genetic vulnerability (5-HTTLPR short allele, BDNF Val66Met, COMT variants)
Metamodel 2 (Epigenetics/Development):
- Early life stress β HPA axis programming β hippocampal vulnerability
- Adverse childhood experiences β smaller hippocampal volume in adulthood
- Transgenerational trauma patterns in bonding system failure
Metamodel 3 (Gut-Immune-Metabolic):
- Gut dysbiosis β LPS translocation β peripheral inflammation β neuroinflammation
- Metabolic dysfunction β β TNF-Ξ± from adipose tissue
- Microbiome-gut-brain axis disruption
Metamodel 4 (Psychosocial-Identity):
- Loss of purpose, meaning, social role β reduced bonding opportunities
- Loneliness β HPA axis activation β cortisol elevation
- Childhood attachment wounds β adult bonding system fragility
Metamodel 5 (Toxic Load):
- Environmental toxins (heavy metals, pesticides) β mitochondrial dysfunction
- Chronic infections (EBV, Borrelia) β sustained immune activation β neuroinflammation
- Electromagnetic pollution β possible sleep disruption β cortisol dysregulation
- This is ONE pathology, not three diseases β the unified bonding system collapse manifests differently depending on which connected brain regions are most affected
- The hippocampus is the pathological hub β its shrinkage and inflammation drive the entire syndrome
- IFN-Ξ³ β IDO β kynurenine pathway is the mechanistic link between inflammation and depression
- "Couch potato" creates a vicious cycle β symptoms β inactivity β β BDNF β worse symptoms
- Hypercortisolemia is both cause and consequence β chronic stress β cortisol β hippocampal damage β impaired HPA negative feedback β more cortisol
- Single-target treatment fails because it addresses symptoms, not the multi-system pathology
- Treatment must be simultaneous multi-system intervention β inflammation, BDNF, cortisol, mitochondria, sensory input, social bonding, regional support
- Hippocampal volume reduction: 10-20% measurable on MRI after 6-12 months chronic stress; primarily affects CA3 and dentate gyrus
- Cortisol neurotoxicity threshold: Sustained levels >20 ΞΌg/dL cause direct hippocampal neuronal death via glutamate excitotoxicity
- TNF-Ξ± in pathological state: Rises from normal 2-5 pg/mL to 15-30 pg/mL in CSF; drives microglial activation and synaptic stripping
- IFN-Ξ³ activation of IDO: Shunts 80-90% of tryptophan toward kynurenine pathway, away from serotonin synthesis
- Kynurenine/Tryptophan ratio >0.05: Diagnostic marker of IDO activation and inflammation-induced depression
- Exercise-induced BDNF increase: 200-300% elevation within 30 minutes of moderate exercise; effect blocked by sedentary behavior
- SSRI failure rate: 67% in STAR*D trial because drugs don't address upstream inflammatory and neuroplastic drivers
- Cognitive reserve depletion: Visual representation of 4 stars β 1 star indicates loss of bonding triad and near-complete reserve exhaustion
- Cortisol circadian flattening: Loss of normal morning peak (15-25 ΞΌg/dL) and evening trough (<5 ΞΌg/dL) is diagnostic of chronic HPA dysregulation
- Mitochondrial ATP reduction: 30-50% decrease in hippocampal neurons under chronic TNF-Ξ± exposure; drives energy-dependent symptoms (fatigue, cognitive dysfunction)
- Allopregnanolone depletion: Reduces GABA-A receptor potentiation by 40-60%, contributing to anxiety and insomnia
- Neurosteroid cascade failure: NGFBP-1 β GR upregulation pathway is disrupted by loss of oxytocin signaling from bonding failure
- bonding system physiology and cognitive reserve β the healthy state from which this pathology develops; same neural architecture, opposite functional state
- photographic medicine β Pruimboom's bonding framework; failure of this system is the ultimate cause of the triad
- imprinting-bonding safety and security β early developmental pathway that establishes hippocampal growth capacity; disruption leads to adult vulnerability
- depression β PFC, substantia nigra, striatum, and ventral tegmental area manifestations of bonding system failure
- chronic pain β amygdala hyperactivation, insular dysfunction, RaphΓ© nuclei compromise, and neuroinflammatory sensitization
- chronic fatigue β mitochondrial energy crisis, hypercortisolemia-induced cortisol resistance, locus coeruleus exhaustion, and TNF-driven sickness behaviour
- TNF-alpha β dominant neuroinflammatory signal; drives microglial activation, synaptic stripping, neurogenesis suppression, and mitochondrial dysfunction
- IFN-gamma β Th1 cytokine that activates IDO enzyme, creating tryptophan steal and quinolinic acid neurotoxicity
- IL-4 β Th2 cytokine appearing in pathological state; reflects dysregulated neuroimmune response attempting failed counter-regulation
- serotonin β depleted through IFN-Ξ³ β IDO β kynurenine pathway; normally synthesized at Nuclei Raphei from tryptophan
- kynurenine pathway β inflammatory diversion of tryptophan; produces neurotoxic quinolinic acid instead of serotonin
- BDNF β brain-derived neurotrophic factor depleted by inflammation and sedentary behavior; essential for hippocampal neurogenesis and synaptic plasticity
- hippocampus β central pathological hub; shrinks 10-20% under chronic stress and inflammation, losing neurons and neurogenic capacity
- glucocorticoid receptors β downregulated by chronic cortisol exposure, creating cortisol resistance and loss of HPA negative feedback
- cortisol β chronically elevated (hypercortisolemia) with flattened circadian rhythm; directly neurotoxic to hippocampal CA3/dentate gyrus
- HPA axis β dysregulated through GR downregulation; loss of negative feedback perpetuates hypercortisolemia
- mitochondria β dysfunctional under TNF-Ξ± and chronic cortisol; 30-50% reduction in ATP production drives fatigue and cognitive symptoms
- Neurosteroids β depleted, particularly allopregnanolone; reduces GABA amplification, worsening anxiety and sleep
- Allopregnanolone β progesterone metabolite that potentiates GABA-A receptors; reduced by 40-60% in chronic stress states
- oxytocin β diminished due to loss of bonding input (touch, social connection); normally drives NGFBP-1 β GR upregulation cascade
- NGFBP-1 β nerve growth factor binding protein-1; cascade from oxytocin β NGFBP-1 β GR upregulation is disrupted in bonding failure
- prefrontal cortex β loses hippocampal regulatory input; manifests as anxiety, rumination, suicidality, impaired executive function
- substantia nigra β dopamine synthesis impaired by TNF-Ξ± inhibition of tyrosine hydroxylase; causes anhedonia and loss of hedonism
- hypothalamus β inflamed by chronic cortisol; leads to HPA axis dysregulation, leptin resistance, appetite disorders, libido loss
- striatum β reward processing failure from reduced dopamine input; manifests as loss of interest and goal-directed behavior
- insular cortex β interoceptive and body awareness disturbances; loss of control over internal states, alexithymia
- amygdala β hyperactivated due to loss of hippocampal inhibition; drives fear, anger, threat hypersensitivity
- locus coeruleus β norepinephrine system exhausted by chronic CRH drive; manifests as nervosity, anxious arousal, sugar craving
- addiction β ventral tegmental area compensatory dopamine-seeking when natural bonding rewards are absent; manifests as compulsive behaviors
- anhedonia β loss of pleasure capacity from substantia nigra and striatal dopamine depletion; core feature of depression
- sickness behaviour β TNF-Ξ± and IL-1Ξ² driven syndrome of fatigue, social withdrawal, anorexia; evolutionary infection response maladaptively triggered
- Highly Sensitive Person β may represent intermediate vulnerability state on continuum toward full bonding system collapse
- cognitive reserve β depleted from four stars to one; this map shows what happens when hippocampal reserve runs out
- Nuclei Raphei β brainstem serotonin source compromised by TNF-Ξ± and tryptophan steal; fails to provide descending pain inhibition
- exercise β single most accessible intervention to break pathological cycle; induces BDNF, myokines, mitochondrial biogenesis
- Intermittent Living β hormetic protocol using cold, fasting, exercise intervals to rebuild neuroplastic reserve and mitochondrial function
- five metamodels β diagnostic framework encompassing genetics, epigenetics, gut-immune-metabolic, psychosocial, and toxic dimensions of this collapse
- IDO β indoleamine 2,3-dioxygenase activated by IFN-Ξ³; diverts tryptophan from serotonin synthesis to neurotoxic kynurenine pathway
- chronic inflammation β upstream driver entering brain through compromised blood-brain barrier; originates from gut dysbiosis, metabolic dysfunction, chronic infection
- neuroinflammation β CNS inflammatory state characterized by microglial M1 activation, elevated TNF-Ξ±/IL-6/IFN-Ξ³, and neuronal damage
- tryptophan β essential amino acid normally converted to serotonin; stolen by IDO activation toward kynurenine in inflammatory states
- piezoelectric channels β mechanosensory TRP3/4 channels activated by physical touch; reduced activation from social isolation decreases oxytocin release
- microglial activation β M1 polarization under TNF-Ξ±/IFN-Ξ³; drives synaptic stripping, cytokine amplification, complement-mediated phagocytosis of synapses
- blood-brain barrier β compromised by peripheral inflammation, allowing cytokines (TNF-Ξ±, IL-6, IFN-Ξ³) to enter CNS and drive neuroinflammation
- stress response β chronically activated; transitions from adaptive (acute cortisol spikes) to maladaptive (sustained hypercortisolemia with GR downregulation)
- gut dysbiosis β altered microbiome composition producing LPS, triggering peripheral inflammation that crosses into CNS
- loneliness β psychological state that activates HPA axis, elevates cortisol, reduces oxytocin, and accelerates bonding system collapse
- Module 11 β The P in PNI (Leo Pruimboom, Feb 2026)
- Raizen (2023) Beyond the symptom: the biology of fatigue
- Fevang et al. (2021) Lasting Immunological Imprint of Primary EBV Infection With Associations to Chronic Low-Grade Inflammation and Fatigue. Front. Immunol.
- Fathy (2019) Differential insular cortex sub-regional atrophy in neurodegenerative diseases. Brain Behaviour and Immunity